.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Deloitte
Covington
Boehringer Ingelheim
Cipla
Julphar
Merck
Healthtrust
Baxter
Dow

Generated: November 20, 2017

DrugPatentWatch Database Preview

Trandolapril - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for trandolapril and what is the scope of trandolapril patent protection?

Trandolapril
is the generic ingredient in four branded drugs marketed by Watson Labs, Cipla, Epic Pharma, Invagen Pharms, Lupin, Abbvie, Aurobindo Pharma, Mylan, Epic Pharma Llc, Teva Pharms, Dr Reddys Labs Ltd, and Glenmark Generics, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for trandolapril. Eight suppliers are listed for this compound.

Pharmacology for trandolapril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
TRANDOLAPRIL
trandolapril
TABLET;ORAL078346-002Apr 28, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Epic Pharma Llc
TRANDOLAPRIL
trandolapril
TABLET;ORAL077256-001Jun 12, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Cipla
TRANDOLAPRIL
trandolapril
TABLET;ORAL077307-001Jun 12, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
TRANDOLAPRIL
trandolapril
TABLET;ORAL078346-001Apr 28, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Lupin
TRANDOLAPRIL
trandolapril
TABLET;ORAL077522-003Jun 12, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TRANDOLAPRIL
trandolapril
TABLET;ORAL077805-003Jun 12, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Generics
TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE
trandolapril; verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL079135-004Aug 30, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Abbvie
TARKA
trandolapril; verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL020591-003Oct 22, 1996ABRXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
TARKA
trandolapril; verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL020591-001Oct 22, 1996ABRXYesNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
TRANDOLAPRIL
trandolapril
TABLET;ORAL078493-002Aug 25, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: trandolapril

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
MAVIK
trandolapril
TABLET;ORAL020528-001Apr 26, 1996► Subscribe► Subscribe
Abbvie
MAVIK
trandolapril
TABLET;ORAL020528-002Apr 26, 1996► Subscribe► Subscribe
Abbvie
MAVIK
trandolapril
TABLET;ORAL020528-002Apr 26, 1996► Subscribe► Subscribe
Abbvie
MAVIK
trandolapril
TABLET;ORAL020528-003Apr 26, 1996► Subscribe► Subscribe
Abbvie
MAVIK
trandolapril
TABLET;ORAL020528-003Apr 26, 1996► Subscribe► Subscribe
Abbvie
MAVIK
trandolapril
TABLET;ORAL020528-003Apr 26, 1996► Subscribe► Subscribe
Abbvie
MAVIK
trandolapril
TABLET;ORAL020528-002Apr 26, 1996► Subscribe► Subscribe
Abbvie
MAVIK
trandolapril
TABLET;ORAL020528-001Apr 26, 1996► Subscribe► Subscribe
Abbvie
MAVIK
trandolapril
TABLET;ORAL020528-001Apr 26, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Moodys
McKinsey
Harvard Business School
Citi
Colorcon
McKesson
Deloitte
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot